Gilead Sciences

Access to Care

Indiana ACLU Sues To Demand Medicaid Reimburse For Hepatitis C Drugs

Jake Harper

Sarah Jackson had quit abusing drugs and was sober for six months before finding out she has hepatitis C. The Fort Wayne, Indiana mom says she was newly…
Costs of Care (old)

Gilead Buys Shortcut For FDA Drug Review For $125 Million

Scott Hensley

The Food and Drug Administration priority review voucher comes from a Canadian company that got it by developing a drug for leishmaniasis, a disease long neglected by pharmaceutical companies.
Community Rx (old)

New Hepatitis C Pill Promises Faster Treatment, At A Higher Cost

Bill Chappell

The new product brings several advances, but it also has a steep price tag, reported at $1,125 per tablet. Its maker reported billions in sales of a related drug approved last year.

Pexels

Pixabay

In each installment of The Checkup, the health reporting team at Side Effects Public Media explores a single question sparked by a recent news story, or maybe by one of our listeners. You can find every episode online, on the radio, or hear us on the WFYI News Now podcast.